MicroRNA regulation of natural killer cells

Frontiers in Immunology

Volumn 4, Issue FRB, 2013, Pages

  Sullivan, Ryan P ^a   Leong, Jeffrey W ^a   Fehniger, Todd A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

MicroRNA; MiRNA; Natural killer

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MICRORNA; MICRORNA 155; MICRORNA 29; MICRORNA 29B; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; RNA INDUCED SILENCING COMPLEX; TRANSCRIPTOME; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY; DISEASE COURSE; DISEASE FREE SURVIVAL; DOWN REGULATION; GAIN OF FUNCTION MUTATION; HUMAN; LOSS OF FUNCTION MUTATION; MICROARRAY ANALYSIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RNA SEQUENCE; UPREGULATION;

EID: 84883658922     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00044     Document Type: Review

References (101)

1. Allantaz, F., Cheng, D. T., Bergauer, T., Ravindran, P., Rossier, M. F., Ebeling, M., et al. (2012). Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS ONE 7:e29979. doi: 10.1371/journal.pone.0029979
2. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355.
3. Bachanova, V., McCullar, V., Lenvik, T., Wangen, R., Peterson, K. A., Ankarlo, D. E. M., et al. (2009). Activated notch supports development of cytokine producing NK cells which are hyporesponsive and fail to acquire NK cell effector functions. Biol. Blood Marrow Transplant. 15, 183-194.
4. Beck, R. C., Padival, M., Yeh, D., Ralston, J., Cooke, K. R., and Lowe, J. B. (2009). The Notch ligands Jagged2, Delta1, and Delta4 induce differentiation and expansion of functional human NK cells from CD34+ cord blood hematopoietic progenitor cells. Biol. Blood Marrow Transplant. 15, 1026-1037.
5. Bezman, N. A., Cedars, E., Steiner, D. F., Blelloch, R., Hesslein, D. G. T., and Lanier, L. L. (2010). Distinct requirements of microRNAs in NK cell activation, survival, and function. J. Immunol. 185, 3835-3846.
6. Bezman, N. A., Chakraborty, T., Bender, T., and Lanier, L. L. (2011). miR-150 regulates the development of NK and iNKT cells. J. Exp. Med. 208, 2717-2731.
7. Brenu, E. W., Ashton, K. J., van Driel, M., Staines, D. R., Peterson, D., Atkinson, G. M., et al. (2012). Cytotoxic lymphocyte microRNAs as prospective biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis. J. Affect. Disord. 141, 261-269.
8. Bryceson, Y. T., and Long, E. O. (2008). Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol. 20, 344-352.
9. Caligiuri, M. A. (2008). Human natural killer cells. Blood 112, 461-469.
10. Chaix, J., Tessmer, M. S., Hoebe, K., Fuséri, N., Ryffel, B., Dalod, M., et al. (2008). Cutting edge: priming of NK cells by IL-18. J. Immunol. 181, 1627-1631.
11. Chen, C.-Z., Li, L., Lodish, H. F., and Bartel, D. P. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86.
12. Chi, S. W., Zang, J. B., Mele, A., and Darnell, R. B. (2009). Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486.
13. Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., and Walzer, T. (2009). Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488-5496.
14. Chong, M. M. W., Rasmussen, J. P., Rudensky, A. Y., Rundensky, A. Y., and Littman, D. R. (2008). The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205, 2005-2017.
15. Cichocki, F., Felices, M., McCullar, V., Presnell, S. R., Al-Attar, A., Lutz, C. T., et al. (2011). Cutting edge: microRNA-181 promotes human NK cell development by regulating notch signaling. J. Immunol. 187, 6171-6175.
16. Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 102, 13944-13949.
17. Colucci, F., Caligiuri, M. A., and Di Santo, J. P. (2003). What does it take to make a natural killer? Nat. Rev. Immunol. 3, 413-425.
18. de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., et al. (2003). Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314-325.
19. Di Santo, J. P. (2006). Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24, 257-286.
20. Di Santo, J. P. (2008). Natural killer cells: diversity in search of a niche. Nat. Immunol. 9, 473-475.
21. Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., et al. (2011). A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117, 1565-1573.
22. Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 102, 3627-3632.
23. Elias, S., and Mandelboim, O. (2012). Battle of the midgets: innate microRNA networking. RNA Biol. 9, 792-798.
24. Fehniger, T. A., Cai, S. F., Cao, X., Bredemeyer, A. J., Presti, R. M., French, A. R., et al. (2007). Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811.
25. Fehniger, T. A., Wylie, T., Germino, E., Leong, J. W., Magrini, V. J., Koul, S., et al. (2010). Next-generation sequencing identifies the natural killer cell microRNA transcriptome. Genome Res. 20, 1590-1604.
26. Filipovich, A. H. (2009). Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology 2009, 127-131.
27. Filipowicz, W., Bhattacharyya, S. N., and Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114.
28. Freud, A. G., and Caligiuri, M. A. (2006). Human natural killer cell development. Immunol. Rev. 214, 56-72.
29. Garcia, D. M., Baek, D., Shin, C., Bell, G. W., Grimson, A., and Bartel, D. P. (2011). Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 18, 1139-1146.
30. Ghisi, M., Corradin, A., Basso, K., Frasson, C., Serafin, V., Mukherjee, S., et al. (2011). Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 117, 7053-7062.
31. Gong, J., Liu, R., Zhuang, R., Zhang, Y., Fang, L., Xu, Z., et al. (2012). miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1. Cancer Sci. 103, 645-652.
32. Haraguchi, K., Suzuki, T., Koyama, N., Kumano, K., Nakahara, F., Matsumoto, A., et al. (2009). Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15. J. Immunol. 182, 6168-6178.
33. He, L., and Hannon, G. J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531.
34. Hesslein, D. G. T., and Lanier, L. L. (2011). Transcriptional control of natural killer cell development and function. Adv. Immunol. 109, 45-85.
35. Huang, Y., Lei, Y., Zhang, H., Hou, L., Zhang, M., and Dayton, A. I. (2011). MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of interleukin-12 signaling in human natural killer cells. Blood 118, 6793-6802.
36. Iorio, M. V., and Croce, C. M. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143-159.
37. Ishida, F., and Kwong, Y.-L. (2010). Diagnosis and management of natural killer-cell malignancies. Exp. Rev. Hematol. 3, 593-602.
38. Jiang, S., Li, C., Olive, V., Lykken, E., Feng, F., Sevilla, J., et al. (2011). Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118, 5487-5497.
39. Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., et al. (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129.
40. Joncker, N. T., and Raulet, D. H. (2008). Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 224, 85-97.
41. Jonsson, H. A., and Yokoyama, W. M. (2009). Natural killer cell tolerance licensing and other mechanisms. Adv. Immunol. 101, 27-79.
42. Karginov, F. V., Conaco, C., Xuan, Z., Schmidt, B. H., Parker, J. S., Mandel, G., et al. (2007). A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. U.S.A. 104, 19291-19296.
43. Khabar, K. S. A., and Young, H. A. (2007). Post-transcriptional control of the interferon system. Biochimie 89, 761-769.
44. Kim, T.-D., Lee, S. U. H., Yun, S., Sun, H., Kim, J. W., Kim, H. M., et al. (2011). Human microRNA-27a * targets Prf1 and GzmB expression to regulate NK cell cytotoxicity. Blood 118, 5476-5486.
45. Kim, V. N. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 376-385.
46. Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q., Mo, T., et al. (2010). The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28-40.
47. Kohlhaas, S., Garden, O. A., Scudamore, C., Turner, M., Okkenhaug, K., and Vigorito, E. (2009). Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol. 182, 2578-2582.
48. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
49. Lanier, L. L. (2005). NK cell recognition. Annu. Rev. Immunol. 23, 225-274.
50. Lanier, L. L. (2008). Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9, 495-502.
51. Lee, S.-H., Miyagi, T., and Biron, C. A. (2007). Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28, 252-259.
52. Lewis, B. P., Shih, I., Jones-Rhoades, M. W., Bartel, D. P., and Burge, C. B. (2003). Prediction of mammalian microRNA targets. Cell 115, 787-798.
53. Li, Q.-J., Chau, J., Ebert, P. J. R., Sylvester, G., Min, H., Liu, G., et al. (2007). miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161.
54. Liu, J. (2008). Control of protein synthesis and mRNA degradation by microRNAs. Curr. Opin. Cell Biol. 20, 214-221.
55. Liu, X., Wang, Y., Sun, Q., Yan, J., Huang, J., Zhu, S., et al. (2012). Identification of microRNA transcriptome involved in human natural killer cell activation. Immunol. Lett. 143, 208-217.
56. Lu, C., Huang, X., Zhang, X., Roensch, K., Cao, Q., Nakayama, K. I., et al. (2011a). miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 117, 4293-4303.
57. Lu, T. X., Hartner, J., Lim, E.-J., Fabry, V., Mingler, M. K., Cole, E. T., et al. (2011b). MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J. Immunol. 187, 3362-3373.
58. Lucas, M., Schachterle, W., Oberle, K., Aichele, P., and Diefenbach, A. (2007). Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503-517.
59. Ma, F., Xu, S., Liu, X., Zhang, Q., Xu, X., Liu, M., et al. (2011). The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol. 12, 861-869.
60. Matkovich, S. J., Van Booven, D. J., Eschenbacher, W. H., and Dorn, G. W. (2011). RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res. 108, 18-26.
61. Mishra, A., Liu, S., Sams, G. H., Curphey, D. P., Santhanam, R., Rush, L. J., et al. (2012). Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell 22, 645-655.
62. Monticelli, S., Ansel, K. M., Xiao, C., Socci, N. D., Krichevsky, A. M., Thai, T. H., et al. (2005). MicroRNA profiling of the murine hematopoietic system. Genome Biol. 6, R71.
63. Muljo, S. A., Ansel, K. M., Kanellopoulou, C., Livingston, D. M., Rao, A., and Rajewsky, K. (2005). Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202, 261-269.
64. Narni-Mancinelli, E., Chaix, J., Fenis, A., Kerdiles, Y. M., Yessaad, N., Reynders, A., et al. (2011). Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl. Acad. Sci. U.S.A. 108, 18324-18329.
65. Neilson, J. R., Zheng, G. X. Y., Burge, C. B., and Sharp, P. A. (2007). Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21, 578-589.
66. Ng, S.-B., Yan, J., Huang, G., Selvarajan, V., Tay, J. L.-S., Lin, B., et al. (2011). Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood 118, 4919-4929.
67. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., and Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U.S.A. 106, 7113-7118.
68. O'Connell, R. M., Kahn, D., Gibson, W. S. J., Round, J. L., Scholz, R. L., Chaudhuri, A. A., et al. (2010a). MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619.
69. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., and Baltimore, D. (2010b). Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10, 111-122.
70. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., and Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 104, 1604-1609.
71. Ofir, M., Hacohen, D., and Ginsberg, D. (2011). miR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol. Cancer Res. 9, 440-447.
72. Orange, J. S., and Ballas, Z. K. (2006). Natural killer cells in human health and disease. Clin. Immunol. 118, 1-10.
73. Paik, J. H., Jang, J.-Y., Jeon, Y. K., Kim, W. Y., Kim, T. M., Heo, D. S., et al. (2011). MicroRNA-146a downregulates NF{kappa}B activity via targeting TRAF6, and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin. Cancer Res. 17, 4761-4771.
74. Ramakrishnan, R., Donahue, H., Garcia, D., Tan, J., Shimizu, N., Rice, A. P., et al. (2011). Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS ONE 6:e27271. doi: 10.1371/journal.pone.0027271
75. Ramirez, K., and Kee, B. L. (2010). Transcriptional regulation of natural killer cell development. Curr. Opin. Immunol. 22, 193-198.
76. Riley, J. K., and Yokoyama, W. M. (2008). NK cell tolerance and the maternal-fetal interface. Am. J. Reprod. Immunol. 59, 371-387.
77. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., et al. (2007). Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611.
78. Rossi, R. L., Rossetti, G., Wenandy, L., Curti, S., Ripamonti, A., Bonnal, R. J. P., et al. (2011). Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4(+) T cells by the microRNA miR-125b. Nat. Immunol. 12, 796-803.
79. Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., and Rajewsky, N. (2008). Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
80. Semenzato, G., Marino, F., and Zambello, R. (2012). State of the art in natural killer cell malignancies. Int. J. Lab. Hematol. 34, 117-128.
81. Spits, H., and Di Santo, J. P. (2011). The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21-27.
82. Steiner, D. F., Thomas, M. F., Hu, J. K., Yang, Z., Babiarz, J. E., Allen, C. D. C., et al. (2011). MicroRNA-29 regulates T-Box transcription factors and interferon-γ production in helper T cells. Immunity 35, 169-181.
83. Storek, J., Geddes, M., Khan, F., Huard, B., Helg, C., Chalandon, Y., et al. (2008). Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin. Immunopathol. 30, 425-437.
84. Sullivan, R. P., Leong, J. W., Schneider, S. E., Keppel, C. K. R., Germino, E., French, A. R., et al. (2012). MicroRNA deficient NK cells exhibit decreased survival but enhanced function. J. Immunol. 188, 3019-3030.
85. Teng, G., Hakimpour, P., Landgraf, P., Rice, A., Tuschl, T., Casellas, R., et al. (2008). MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28, 621-629.
86. Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., et al. (2007). Regulation of the germinal center response by microRNA-155. Science 316, 604-608.
87. Thomas, M. F., Abdul-Wajid, S., Panduro, M., Babiarz, J. E., Rajaram, M., Woodruff, P., et al. (2012). Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. Blood 120, 130-142.
88. Trotta, R., Chen, L., Ciarlariello, D., Josyula, S., Mao, C., Costinean, S., et al. (2012). MiR-155 regulates IFN-γ production in natural killer cells. Blood 119, 3478-3485.
89. Vasudevan, S., Tong, Y., and Steitz, J. A. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934.
90. Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., et al. (2007). microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27, 847-859.
91. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S. (2008). Functions of natural killer cells. Nat. Immunol. 9, 503-510.
92. Wang, P., Gu, Y., Zhang, Q., Han, Y., Hou, J., Lin, L., et al. (2012). Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. J. Immunol. 189, 211-221.
93. Wang, X. (2008). miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14, 1012-1017.
94. Watters, R. J., Liu, X., and Loughran, T. P. (2011). T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk. Lymphoma 52, 2217-2225.
95. Winter, J., Jung, S., Keller, S., Gregory, R. I., and Diederichs, S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234.
96. Wu, L., and Belasco, J. G. (2008). Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol. Cell 29, 1-7.
97. Xiao, C., Calado, D. P., Galler, G., Thai, T. H., Patterson, H. C., Wang, J., et al. (2007). MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146-159.
98. Yamanaka, Y., Tagawa, H., Takahashi, N., Watanabe, A., Guo, Y.-M., Iwamoto, K., et al. (2009). Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 114, 3265-3275.
99. Yokoyama, W. M., Kim, S., and French, A. R. (2004). The dynamic life of natural killer cells. Annu. Rev. Immunol. 22, 405-429.
100. Young, H. R. (1996). Regulation of interferon-gamma gene expression. J. Interferon Cytokine Res. 568, 563-568.
101. Zhou, B., Wang, S., Mayr, C., Bartel, D. P., and Lodish, H. F. (2007). miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. U.S.A. 104, 7080-7085.